ID   LDLR_RAT                Reviewed;         879 AA.
AC   P35952;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   24-JUL-2024, entry version 177.
DE   RecName: Full=Low-density lipoprotein receptor;
DE            Short=LDL receptor;
DE   Flags: Precursor;
GN   Name=Ldlr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=2922268; DOI=10.1093/nar/17.3.1259;
RA   Lee L.Y., Mohler W.A., Schafer B.L., Freudenberger J.S., Byrne-Connolly N.,
RA   Eager K.B., Mosley S.T., Leighton J.K., Thrift R.N., Davis R.A.,
RA   Tanaka R.D.;
RT   "Nucleotide sequence of the rat low density lipoprotein receptor cDNA.";
RL   Nucleic Acids Res. 17:1259-1260(1989).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-717; THR-724; THR-732;
RP   THR-733 AND SER-734, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
CC   -!- FUNCTION: Binds low density lipoprotein /LDL, the major cholesterol-
CC       carrying lipoprotein of plasma, and transports it into cells by
CC       endocytosis. In order to be internalized, the receptor-ligand complexes
CC       must first cluster into clathrin-coated pits. Forms a ternary complex
CC       with PGRMC1 and TMEM97 receptors which increases LDLR-mediated LDL
CC       internalization. {ECO:0000250|UniProtKB:P01130}.
CC   -!- SUBUNIT: Interacts (via NPXY motif) with DAB2 (via PID domain); the
CC       interaction is impaired by tyrosine phosphorylation of the NPXY motif
CC       (By similarity). Interacts (via NPXY motif) with LDLRAP1 (via PID
CC       domain). Interacts with ARRB1. Interacts with SNX17. Interacts with the
CC       full-length immature form of PCSK9 (via C-terminus) (By similarity).
CC       Interacts with PGRMC1 and TMEM97; the interaction increases LDL
CC       internalization (By similarity). {ECO:0000250|UniProtKB:P01130,
CC       ECO:0000250|UniProtKB:P35951}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P01130};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P01131}.
CC       Membrane, clathrin-coated pit {ECO:0000250|UniProtKB:P01130}. Golgi
CC       apparatus {ECO:0000250|UniProtKB:P01130}. Early endosome
CC       {ECO:0000250|UniProtKB:P01130}. Late endosome
CC       {ECO:0000250|UniProtKB:P01130}. Lysosome
CC       {ECO:0000250|UniProtKB:P01130}. Note=Rapidly endocytosed upon ligand
CC       binding. {ECO:0000250|UniProtKB:P01130}.
CC   -!- DOMAIN: The NPXY motif mediates the interaction with the clathrin
CC       adapter DAB2 and with LDLRAP1 which are involved in receptor
CC       internalization. A few residues outside the motif also play a role in
CC       the interaction. {ECO:0000250|UniProtKB:P01130}.
CC   -!- PTM: N- and O-glycosylated. {ECO:0000250|UniProtKB:P01130}.
CC   -!- PTM: Ubiquitinated by MYLIP leading to degradation.
CC       {ECO:0000250|UniProtKB:P01130}.
CC   -!- SIMILARITY: Belongs to the LDLR family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X13722; CAA32001.1; -; mRNA.
DR   PIR; S03430; QRRTLD.
DR   RefSeq; NP_786938.1; NM_175762.2.
DR   AlphaFoldDB; P35952; -.
DR   SMR; P35952; -.
DR   STRING; 10116.ENSRNOP00000013496; -.
DR   GlyCosmos; P35952; 4 sites, No reported glycans.
DR   GlyGen; P35952; 4 sites.
DR   iPTMnet; P35952; -.
DR   PhosphoSitePlus; P35952; -.
DR   jPOST; P35952; -.
DR   PaxDb; 10116-ENSRNOP00000013496; -.
DR   GeneID; 300438; -.
DR   KEGG; rno:300438; -.
DR   UCSC; RGD:2998; rat.
DR   AGR; RGD:2998; -.
DR   CTD; 3949; -.
DR   RGD; 2998; Ldlr.
DR   eggNOG; KOG1215; Eukaryota.
DR   InParanoid; P35952; -.
DR   OrthoDB; 3918101at2759; -.
DR   PhylomeDB; P35952; -.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8964026; Chylomicron clearance.
DR   Reactome; R-RNO-8964038; LDL clearance.
DR   PRO; PR:P35952; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0045177; C:apical part of cell; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0005905; C:clathrin-coated pit; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; ISS:UniProtKB.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0005770; C:late endosome; ISS:UniProtKB.
DR   GO; GO:0034362; C:low-density lipoprotein particle; IEA:UniProtKB-KW.
DR   GO; GO:0005764; C:lysosome; ISS:UniProtKB.
DR   GO; GO:1990666; C:PCSK9-LDLR complex; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0055038; C:recycling endosome membrane; IDA:RGD.
DR   GO; GO:0036477; C:somatodendritic compartment; ISO:RGD.
DR   GO; GO:0097443; C:sorting endosome; ISO:RGD.
DR   GO; GO:0001540; F:amyloid-beta binding; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0071813; F:lipoprotein particle binding; IBA:GO_Central.
DR   GO; GO:0030169; F:low-density lipoprotein particle binding; ISO:RGD.
DR   GO; GO:0005041; F:low-density lipoprotein particle receptor activity; IDA:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0002020; F:protease binding; ISO:RGD.
DR   GO; GO:0030229; F:very-low-density lipoprotein particle receptor activity; ISO:RGD.
DR   GO; GO:0097242; P:amyloid-beta clearance; ISO:RGD.
DR   GO; GO:0150094; P:amyloid-beta clearance by cellular catabolic process; ISO:RGD.
DR   GO; GO:0048844; P:artery morphogenesis; ISO:RGD.
DR   GO; GO:0071398; P:cellular response to fatty acid; ISO:RGD.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; ISO:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; IEP:RGD.
DR   GO; GO:0070508; P:cholesterol import; ISO:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0030301; P:cholesterol transport; ISO:RGD.
DR   GO; GO:0006897; P:endocytosis; IMP:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0034384; P:high-density lipoprotein particle clearance; ISO:RGD.
DR   GO; GO:0030299; P:intestinal cholesterol absorption; ISO:RGD.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:RGD.
DR   GO; GO:0042159; P:lipoprotein catabolic process; ISO:RGD.
DR   GO; GO:0042157; P:lipoprotein metabolic process; ISO:RGD.
DR   GO; GO:0007616; P:long-term memory; ISO:RGD.
DR   GO; GO:0034383; P:low-density lipoprotein particle clearance; ISO:RGD.
DR   GO; GO:1905907; P:negative regulation of amyloid fibril formation; ISO:RGD.
DR   GO; GO:0061889; P:negative regulation of astrocyte activation; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0010989; P:negative regulation of low-density lipoprotein particle clearance; ISO:RGD.
DR   GO; GO:1903979; P:negative regulation of microglial cell activation; ISO:RGD.
DR   GO; GO:0051248; P:negative regulation of protein metabolic process; ISO:RGD.
DR   GO; GO:0001920; P:negative regulation of receptor recycling; ISO:RGD.
DR   GO; GO:0006909; P:phagocytosis; ISO:RGD.
DR   GO; GO:0015914; P:phospholipid transport; ISO:RGD.
DR   GO; GO:0034381; P:plasma lipoprotein particle clearance; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISO:RGD.
DR   GO; GO:1905167; P:positive regulation of lysosomal protein catabolic process; ISO:RGD.
DR   GO; GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISO:RGD.
DR   GO; GO:0010898; P:positive regulation of triglyceride catabolic process; IMP:RGD.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISO:RGD.
DR   GO; GO:0090118; P:receptor-mediated endocytosis involved in cholesterol transport; ISO:RGD.
DR   GO; GO:0090181; P:regulation of cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0010899; P:regulation of phosphatidylcholine catabolic process; ISO:RGD.
DR   GO; GO:0051246; P:regulation of protein metabolic process; ISO:RGD.
DR   GO; GO:0061771; P:response to caloric restriction; ISO:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0033762; P:response to glucagon; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   CDD; cd00054; EGF_CA; 2.
DR   CDD; cd00112; LDLa; 6.
DR   Gene3D; 4.10.1220.10; EGF-type module; 1.
DR   Gene3D; 2.10.25.10; Laminin; 3.
DR   Gene3D; 4.10.400.10; Low-density Lipoprotein Receptor; 6.
DR   Gene3D; 2.120.10.30; TolB, C-terminal domain; 1.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR036055; LDL_receptor-like_sf.
DR   InterPro; IPR050685; LDLR.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR000033; LDLR_classB_rpt.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR049883; NOTCH1_EGF-like.
DR   PANTHER; PTHR24270; LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED; 1.
DR   PANTHER; PTHR24270:SF8; VERY LOW-DENSITY LIPOPROTEIN RECEPTOR; 1.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF14670; FXa_inhibition; 2.
DR   Pfam; PF00057; Ldl_recept_a; 7.
DR   Pfam; PF00058; Ldl_recept_b; 5.
DR   PRINTS; PR00261; LDLRECEPTOR.
DR   SMART; SM00181; EGF; 4.
DR   SMART; SM00179; EGF_CA; 2.
DR   SMART; SM00192; LDLa; 7.
DR   SMART; SM00135; LY; 5.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   SUPFAM; SSF57424; LDL receptor-like module; 7.
DR   SUPFAM; SSF63825; YWTD domain; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 2.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01187; EGF_CA; 1.
DR   PROSITE; PS01209; LDLRA_1; 7.
DR   PROSITE; PS50068; LDLRA_2; 7.
DR   PROSITE; PS51120; LDLRB; 5.
PE   1: Evidence at protein level;
KW   Cell membrane; Cholesterol metabolism; Coated pit; Disulfide bond;
KW   EGF-like domain; Endocytosis; Endosome; Glycoprotein; Golgi apparatus; LDL;
KW   Lipid metabolism; Lipid transport; Lysosome; Membrane; Phosphoprotein;
KW   Receptor; Reference proteome; Repeat; Signal; Steroid metabolism;
KW   Sterol metabolism; Transmembrane; Transmembrane helix; Transport;
KW   Ubl conjugation.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000250|UniProtKB:P01131"
FT   CHAIN           22..879
FT                   /note="Low-density lipoprotein receptor"
FT                   /id="PRO_0000017314"
FT   TOPO_DOM        22..807
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P01131"
FT   TRANSMEM        808..829
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        830..879
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P01130"
FT   DOMAIN          25..65
FT                   /note="LDL-receptor class A 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          66..106
FT                   /note="LDL-receptor class A 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          107..145
FT                   /note="LDL-receptor class A 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          146..186
FT                   /note="LDL-receptor class A 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          196..234
FT                   /note="LDL-receptor class A 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          235..273
FT                   /note="LDL-receptor class A 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          275..314
FT                   /note="LDL-receptor class A 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          315..354
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          355..394
FT                   /note="EGF-like 2; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          398..439
FT                   /note="LDL-receptor class B 1"
FT   REPEAT          440..485
FT                   /note="LDL-receptor class B 2"
FT   REPEAT          486..528
FT                   /note="LDL-receptor class B 3"
FT   REPEAT          529..572
FT                   /note="LDL-receptor class B 4"
FT   REPEAT          573..615
FT                   /note="LDL-receptor class B 5"
FT   REPEAT          616..658
FT                   /note="LDL-receptor class B 6"
FT   DOMAIN          663..712
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          717..788
FT                   /note="Clustered O-linked oligosaccharides"
FT   REGION          718..797
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          830..879
FT                   /note="Required for MYLIP-triggered down-regulation of
FT                   LDLR"
FT                   /evidence="ECO:0000250|UniProtKB:P01130"
FT   MOTIF           842..847
FT                   /note="NPXY motif"
FT                   /evidence="ECO:0000250|UniProtKB:P01130"
FT   COMPBIAS        718..733
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        742..759
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        760..792
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         717
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         724
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         732
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         733
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         734
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   CARBOHYD        97
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        156
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        273
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        657
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        27..39
FT                   /evidence="ECO:0000250"
FT   DISULFID        34..52
FT                   /evidence="ECO:0000250"
FT   DISULFID        46..63
FT                   /evidence="ECO:0000250"
FT   DISULFID        68..82
FT                   /evidence="ECO:0000250"
FT   DISULFID        75..95
FT                   /evidence="ECO:0000250"
FT   DISULFID        89..104
FT                   /evidence="ECO:0000250"
FT   DISULFID        109..121
FT                   /evidence="ECO:0000250"
FT   DISULFID        116..134
FT                   /evidence="ECO:0000250"
FT   DISULFID        128..143
FT                   /evidence="ECO:0000250"
FT   DISULFID        148..160
FT                   /evidence="ECO:0000250"
FT   DISULFID        155..173
FT                   /evidence="ECO:0000250"
FT   DISULFID        167..184
FT                   /evidence="ECO:0000250"
FT   DISULFID        198..210
FT                   /evidence="ECO:0000250"
FT   DISULFID        205..223
FT                   /evidence="ECO:0000250"
FT   DISULFID        217..232
FT                   /evidence="ECO:0000250"
FT   DISULFID        237..249
FT                   /evidence="ECO:0000250"
FT   DISULFID        244..262
FT                   /evidence="ECO:0000250"
FT   DISULFID        256..271
FT                   /evidence="ECO:0000250"
FT   DISULFID        277..290
FT                   /evidence="ECO:0000250"
FT   DISULFID        285..303
FT                   /evidence="ECO:0000250"
FT   DISULFID        297..314
FT                   /evidence="ECO:0000250"
FT   DISULFID        319..330
FT                   /evidence="ECO:0000250"
FT   DISULFID        326..339
FT                   /evidence="ECO:0000250"
FT   DISULFID        341..353
FT                   /evidence="ECO:0000250"
FT   DISULFID        359..369
FT                   /evidence="ECO:0000250"
FT   DISULFID        365..378
FT                   /evidence="ECO:0000250"
FT   DISULFID        380..393
FT                   /evidence="ECO:0000250"
FT   DISULFID        667..681
FT                   /evidence="ECO:0000250"
FT   DISULFID        677..696
FT                   /evidence="ECO:0000250"
FT   DISULFID        698..711
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   879 AA;  96622 MW;  E89F354E3F7C9005 CRC64;
     MSTADLMLRW AIALLLAAAG VAAEDSCGKN EFQCRDGKCI VSKWVCDGSR ECPDGSDESP
     ETCMSVTCRS GEFSCGGRVS RCIPDSWRCD GRTDCENGSD ELDCSPKTCS LDEFRCQDGK
     CISRQFVCDQ DWDCLDGSDE AHCAATTCGP AHFRCNSSSC IPSLWACDGD RDCDDGSDEW
     PQNCGAEDTA AEVVSSPCSS LEFHCGSSEC IHRSWVCDGA ADCKDKSDEE NCAVTTCRPD
     EFQCADGSCI HGSRQCDREH DCKDMSDELG CINVTQCDGP NKFKCHSGEC ISLDKVCNSA
     RDCRDWSDEP IKECKTNECL DNNGGCSHIC KDLKIGYECL CPSGFRLVDG HQCEDIDECQ
     EPDTCSQLCV NLEGSFKCEC RAGFHMDPHT RVCKAVGSIG FLLFTNRHEV RKMTLDRSEY
     TSLIPNLKNV VALDTEVANN RIYWSDLSQR KIYSAVMDQG TSLSYDAIIS GDLHAPDGLA
     VDWIHGNIYW TDSVPGTVSV ADTKGVRRRT LFREKGSRPR AIVVDPVHGF MYWTDWGTPA
     KIKKGGLNGV DIYSLVTEDI QWPNGITLDL PSGRLYWVDS KLHSISSIDV NGGGRKTILE
     DEKQLAHPFS LAIYEDKVYW TDVLNEAIFS ANRLTGSDVN LVAKNLMSPE DIVLFHNVTQ
     PRGVNWCEAT VLPNGGCQYM CLPAPQISAH SPKFTCACPD GMLLAKDMRS CLPEVDTVPT
     TQGTSTIGPV VTTSAAVSLK RKEDPSATRH KEDPSATRHN EDPSATSTSR QPGDTPELST
     VESVTVSSQV QGDMAGRGDE VQRHGVGFLS IFLPIALVAL LVFGAILLWR NWRLRNINSI
     NFDNPVYQKT TEDEIHICRS QDGYTYPSRQ MVSLEDDVA
//
